Ansell (ASX:ANN) Current Accrued Expense: A$0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ANN Ansell Ltd ASX:ANN
76 GF Score
Price A$31.82
GF Value A$29.52
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ansell Current Accrued Expense?

Ansell ASX:ANN -1.27% 76 Current Accrued Expense is A$0 Mil as of Dec. 2025. GuruFocus rates ASX:ANN with a GF Score™ of 76/100 and a GF Value™ of A$29.52 (Fairly Valued). The stock has 4 warning signs investors should review.

Ansell's Current Accrued Expense for the quarter that ended in Dec. 2025 was A$0 Mil.


Ansell Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Ansell's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ansell Current Accrued Expense Chart

Ansell Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ansell Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:ANN
76GF Score
Ansell Ltd ASX:ANN
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ansell Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of A$0 Mil mean?
Ansell (ASX:ANN) has a Current Accrued Expense of A$0 Mil as of Dec. 2025. Current Accrued Expense records the total amount of accrued expenses. View historical data on Ansell and its competitors.
Is Ansell's Current Accrued Expense too high?
Ansell's current Current Accrued Expense is A$0 Mil. Overall, Ansell has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ansell's Current Accrued Expense compare to ISRG and BDX?
Ansell's Current Accrued Expense of A$0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Ansell and its competitors. Ansell's current Current Accrued Expense is A$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Based on GuruFocus' analysis, Ansell (ASX:ANN) is currently considered Fairly Valued. The stock's GF Value™ is A$29.52, compared to a current price of A$31.82 — trading 7.8% above its estimated fair value. The current Current Accrued Expense is A$0 Mil. Ansell's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Ansell (ASX:ANN), the current Current Accrued Expense is A$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ansell (ASX:ANN) Overvalued in 2026?

Based on GuruFocus' analysis, Ansell stock appears to be overvalued. The current stock price of A$31.82 is trading 7.8% above its estimated GF Value™ of A$29.52. GuruFocus considers Ansell to be Fairly Valued.

Key valuation signals for ASX:ANN:

  • Current Accrued Expense: A$0 Mil
  • GF Value™: A$29.52 vs. price of A$31.82 (7.8% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the ASX:ANN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ansell Business Description

Address 678 Victoria Street, Level 3, Richmond, Melbourne, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
76GF Score

Get the complete analysis for ASX:ANN

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$31.82
Price
A$29.52
GF Value